- Thread starter
- #541
Ritonavir inhibits CYP2D6. These drug interactions are not well documented:
Jun 2021 CYP2D6 Coronavirus
pubmed.ncbi.nlm.nih.gov
’....Ritonavir inhibits CYP2D6....Many cardiology, pulmonology, and intensivist physicians have never been exposed to clinical scenarios requiring co-prescription of cardiac and antiviral therapies.’
Oct 2020 Spain: CYP2D6 / SARS-CoV / Loss-of-Function
pubmed.ncbi.nlm.nih.gov
Jun 2021 CYP2D6 Coronavirus
![pubmed.ncbi.nlm.nih.gov](https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image-v2.jpg)
Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications - PubMed
Lopinavir-ritonavir combination is being used for the treatment of SARS-CoV-2 infection. A low dose of ritonavir is added to other protease inhibitors to take advantage of potent inhibition of cytochrome (CYP) P450 3A4, thereby significantly increasing the plasma concentration of coadministered...
![pubmed.ncbi.nlm.nih.gov](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png)
Oct 2020 Spain: CYP2D6 / SARS-CoV / Loss-of-Function
![pubmed.ncbi.nlm.nih.gov](https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image-v2.jpg)
Towards Accurate Genotype-Phenotype Correlations in the CYP2D6 Gene - PubMed
Establishing accurate and large-scale genotype-phenotype correlations and predictions of individual response to pharmacological treatments are two of the <i>holy grails</i> of Personalized Medicine. These tasks are challenging and require an integrated knowledge of the complex processes that...
![pubmed.ncbi.nlm.nih.gov](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png)